Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP367077.RAFqGwVA89LANwzjYmD8AsbJfvo2IroV3kDrMJCTm2mL0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP367077.RAFqGwVA89LANwzjYmD8AsbJfvo2IroV3kDrMJCTm2mL0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP367077.RAFqGwVA89LANwzjYmD8AsbJfvo2IroV3kDrMJCTm2mL0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP367077.RAFqGwVA89LANwzjYmD8AsbJfvo2IroV3kDrMJCTm2mL0130_provenance.
- NP367077.RAFqGwVA89LANwzjYmD8AsbJfvo2IroV3kDrMJCTm2mL0130_assertion description "[NAT2 (arylamine N-acetyltransferase 2) polymorphism, being a key determinant of individual variations in acetylation capacity, is suspected to modify the risk of carcinogen-related malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP367077.RAFqGwVA89LANwzjYmD8AsbJfvo2IroV3kDrMJCTm2mL0130_provenance.
- NP367077.RAFqGwVA89LANwzjYmD8AsbJfvo2IroV3kDrMJCTm2mL0130_assertion evidence source_evidence_literature NP367077.RAFqGwVA89LANwzjYmD8AsbJfvo2IroV3kDrMJCTm2mL0130_provenance.
- NP367077.RAFqGwVA89LANwzjYmD8AsbJfvo2IroV3kDrMJCTm2mL0130_assertion SIO_000772 15808403 NP367077.RAFqGwVA89LANwzjYmD8AsbJfvo2IroV3kDrMJCTm2mL0130_provenance.
- NP367077.RAFqGwVA89LANwzjYmD8AsbJfvo2IroV3kDrMJCTm2mL0130_assertion wasDerivedFrom befree-20140225 NP367077.RAFqGwVA89LANwzjYmD8AsbJfvo2IroV3kDrMJCTm2mL0130_provenance.
- NP367077.RAFqGwVA89LANwzjYmD8AsbJfvo2IroV3kDrMJCTm2mL0130_assertion wasGeneratedBy ECO_0000203 NP367077.RAFqGwVA89LANwzjYmD8AsbJfvo2IroV3kDrMJCTm2mL0130_provenance.
- befree-20140225 importedOn "2014-02-25" NP367077.RAFqGwVA89LANwzjYmD8AsbJfvo2IroV3kDrMJCTm2mL0130_provenance.